Matthew Blischak
Vorstandsvorsitzender bei FINCH THERAPEUTICS GROUP, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Matthew Blischak
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Vorstandsvorsitzender | 16.05.2023 | - |
| Präsident | 16.05.2023 | - | |
| Unternehmenssekretär | 16.05.2023 | - |
Karriereverlauf von Matthew Blischak
Ehemalige bekannte Positionen von Matthew Blischak
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.05.2018 | 01.04.2023 |
Ausbildung von Matthew Blischak
| Case Western Reserve University | Undergraduate Degree |
| American University Washington College of Law | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| 2 |
Operativ
| Graduate Degree | 2 |
| Chief Executive Officer | 1 |
| President | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Finch Therapeutics Group, Inc. | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
- Börse
- Insiders
- Matthew Blischak
- Erfahrung
